- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD) in New Zealand
Total 5822 results
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Argentina, Germany, Spain, South Africa, Mexico, Peru, Netherlands, Canada, United Kingdom, Denmark, Chile, Italy, Sweden
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Canada, Germany, Spain, United States, Italy, Netherlands, South Africa, Sweden, France, Mexico, Australia
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaboratorsTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingExamining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) (COPDGene)Pulmonary Disease, Chronic Obstructive | Emphysema | Bronchitis, ChronicUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSouth Africa, United States, Canada, Ukraine, United Kingdom, Denmark, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Canada, Germany, Poland, Romania, Spain, United States, Korea, Republic of, Netherlands
-
University of MinnesotaUniversity of Alabama at Birmingham; United States Department of DefenseTerminatedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Russian Federation, Spain, Bulgaria, Canada, Hungary, Argentina
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, Japan, Russian Federation, Spain, Germany, Mexico, Romania, Korea, Republic of, Poland, Italy, France
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany, Hungary, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Taiwan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveCanada, United States
-
VA New York Harbor Healthcare SystemUnknownPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Netherlands, Portugal, Ukraine, United Kingdom
-
GlaxoSmithKlineParexelCompletedPulmonary Disease, Chronic ObstructivePoland, United States, Russian Federation
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveNetherlands, Belgium, United States
-
Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseGermany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
Columbia UniversityCompletedEmphysemaUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany
-
PfizerTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Canada, United Kingdom, Poland, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany
-
BayerNovartisCompletedBronchiectasis | Pulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Russian Federation, Chile, Poland, Mexico, Estonia, Korea, Republic of, Philippines
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Brazil, Canada, China, Colombia, Croatia, Germany, Hungary, India, Ireland, Japan, Norway, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Germany, Estonia, Chile, Netherlands, Peru, South Africa, Sweden, Mexico, United Kingdom, Italy, Philippines, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Poland, Romania, Russian Federation, Ukraine, Bulgaria, Estonia, Mexico, Korea, Republic of, Slovakia, Greece, China, Italy, Hungary, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Russian Federation, Ukraine, United States, South Africa, Korea, Republic of, Romania, Canada, France, Italy, Chile, Denmark
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Guatemala, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian... and more
-
Columbia UniversityCompletedPulmonary Disease, Chronic Obstructive | E-cigarettesUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Latv... and more
-
Institut für Pneumologie Hagen Ambrock eVFisher and Paykel HealthcareCompleted
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Costa Rica, Brazil, Chile, Mexico, Argentina
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Romania, Russian Federation, United States, Ukraine
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Romania, Russian Federation, Ukraine, Argentina, Poland, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Mexico, Norway
-
Janssen Research & Development, LLCCompletedPulmonary Disease, Chronic Obstructive | AsthmaUnited States, France, United Kingdom, Germany, Canada, Netherlands, Romania, Denmark
-
GlaxoSmithKlineTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, France, Germany, Poland, Romania, Russian Federation, Spain, United States, Netherlands, Sweden, Korea, Republic of, Canada, United Kingdom, Italy, Mexico
-
Grifols Therapeutics LLCEnrolling by invitationPulmonary Emphysema in Alpha-1 Antitrypsin DeficiencyUnited States, New Zealand, Denmark, Australia, Finland, Estonia, Canada, Poland, Russian Federation, Sweden, France
-
Forest LaboratoriesCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Chile, Romania, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Germany, Japan, Romania, Ukraine, Chile, Korea, Republic of, Taiwan, Netherlands, United Kingdom, Canada, Denmark, Australia, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Ukraine, Germany, Peru, Poland, France, Romania, Italy, Mexico
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Canada, Spain, United States, Finland, Italy, Russian Federation, United Kingdom, New Zealand, Australia, France, Greece, Ireland, Netherlands, South Africa
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, China, Germany, Taiwan